CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 82.12% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money
52.74
0.67%
Market Trading Hours* (UTC) Opens on Wednesday at 07:00

Mon - Fri: 07:00 - 15:30

  • Summary
  • Historical Data
Trading сonditions
Spread 0.17
Long position overnight fee

Long position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.017946 %
Charges from full value of position ($-3.41)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.017946%
Short position overnight fee

Short position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.004276 %
Charges from full value of position ($-0.81)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.004276%
Overnight fee time 21:00 (UTC)
Min traded quantity 0.1
Currency EUR
Margin 5.00%
Stock exchange Italy
Commission on trade 0%

Key Stats
Prev. Close 52.39
Open 52.74
1-Year Change 3.43%
Day's Range 52.39 - 53.04
  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Mar 31, 2025 52.39 -0.40 -0.76% 52.79 52.94 51.94
Mar 28, 2025 52.99 0.10 0.19% 52.89 53.39 52.59
Mar 27, 2025 53.19 0.55 1.04% 52.64 53.54 52.39
Mar 26, 2025 52.79 -1.05 -1.95% 53.84 53.84 52.69
Mar 25, 2025 53.84 0.55 1.03% 53.29 54.19 53.29
Mar 24, 2025 53.34 -0.25 -0.47% 53.59 53.59 52.94
Mar 21, 2025 53.24 0.10 0.19% 53.14 53.89 52.74
Mar 20, 2025 53.79 0.95 1.80% 52.84 53.89 52.84
Mar 19, 2025 52.99 -0.75 -1.40% 53.74 53.74 52.94
Mar 18, 2025 53.44 0.10 0.19% 53.34 53.49 52.94
Mar 17, 2025 53.14 0.60 1.14% 52.54 53.14 52.54
Mar 14, 2025 52.44 -0.35 -0.66% 52.79 52.89 52.19
Mar 13, 2025 52.89 0.65 1.24% 52.24 52.99 52.24
Mar 12, 2025 52.79 0.60 1.15% 52.19 53.19 52.19
Mar 11, 2025 52.34 -1.95 -3.59% 54.29 54.34 52.04
Mar 10, 2025 53.99 0.65 1.22% 53.34 54.09 53.34
Mar 7, 2025 53.29 0.10 0.19% 53.19 53.39 52.49
Mar 6, 2025 53.34 -0.30 -0.56% 53.64 53.74 52.49
Mar 5, 2025 53.79 -0.15 -0.28% 53.94 54.34 53.44
Mar 4, 2025 54.24 -0.30 -0.55% 54.54 54.99 54.24

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
  • 2:1
  • 3:1
  • 5:1
  • 10:1
  • 20:1
Leverage
20:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Recordati Company profile

About Recordati Industria Chimica e Farma SpA

Recordati Industria Chimica e Farmaceutica SpA is an Italy-based group engaged in the research, development, manufacture and marketing of pharmaceuticals. It promotes a wide range of pharmaceuticals, both proprietary and under license, in a number of therapeutic areas, such as Antibiotics and Antiviral, Cardiovascular, Central nervous system, Dermatological, Gastroenterology, Genital-urinary system, Muscular-skeletal disorders and pain therapy, Obstetrics and Gynecology and over the counter (OTC) pharmaceuticals. The Company is engaged in the research and development of new drug entities within the cardiovascular and urogenital therapeutic areas and of treatments for rare diseases. It’s product is ZANIDIP, a latest generation calcium-channel blocker for the treatment hypertension. It operates through Italchimici SpA, Pro Farma AG and North American marketing rights to Cystadane. The Company owns and operates through Natural Point srl also in the food supplement sector.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, Recordati Industria Chimica e Farma SpA revenues increased 9% to EUR1.58B. Net income increased 9% to EUR386M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Dividend per share increased from EUR1.05 to EUR1.10. Basic Earnings per Share excluding Extraordinary Items increased from EUR1.73 to EUR1.87.

Industry: Pharmaceuticals (NEC)

Via M. Civitali, 1
MILANO
MILANO 20148
IT

People also watch

BTC/USD

85,262.70 Price
+3.410% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 50.00

US100

19,467.90 Price
+1.300% 1D Chg, %
Long position overnight fee -0.0237%
Short position overnight fee 0.0015%
Overnight fee time 21:00 (UTC)
Spread 1.8

Gold

3,116.18 Price
-0.260% 1D Chg, %
Long position overnight fee -0.0161%
Short position overnight fee 0.0079%
Overnight fee time 21:00 (UTC)
Spread 0.30

XRP/USD

2.14 Price
+2.530% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 0.01070

Still looking for a broker you can trust?

Join the 710,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading